Medtronic, Inc. (MDT)

ikkyu2 (98.66) Submitted: 10/03/06 11:12 AM : Start Price: $46.20 MDT Score: 21.69

I like 'em short, medium, and long. CW analysis focuses on their cardiac pacemakers, which comprises less than 60% of their business and dropping with every year. Never mind that they've got the best, non-recalled pacemakers in the field (unlike Guidant/St. Jude); check out their pipeline. Leaders in coated stents, leaders in minimally invasive back surgery (reducing rehab time from 6 weeks to 6 days), and their neurological pipeline is extremely exciting.

And, they're financing aggressively for growth and acquisition with well-timed issuances and buyback of convertible debentures. I'm a fan!

Report this Post Replies: 0 | Reply